
Robert A. Vetere
Examiner (ID: 7087, Phone: (571)270-1864 , Office: P/1712 )
| Most Active Art Unit | 1712 |
| Art Unit(s) | 1792, 1712 |
| Total Applications | 1040 |
| Issued Applications | 588 |
| Pending Applications | 102 |
| Abandoned Applications | 387 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12178644
[patent_doc_number] => 20180037579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/462326
[patent_app_country] => US
[patent_app_date] => 2017-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 59645
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15462326
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/462326 | COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES | Mar 16, 2017 | Abandoned |
Array
(
[id] => 15320769
[patent_doc_number] => 20200000714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => OPHTHALMIC COMPOSITION COMPRISING PVP-I
[patent_app_type] => utility
[patent_app_number] => 16/092173
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092173
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092173 | OPHTHALMIC COMPOSITION COMPRISING PVP-I | Feb 16, 2017 | Pending |
Array
(
[id] => 11588357
[patent_doc_number] => 20170112768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'DIRECTLY COMPRESSIBLE GRANULAR MICROCRYSTALLINE CELLULOSE BASED EXCIPIENT, MANUFACTURING PROCESS AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/398207
[patent_app_country] => US
[patent_app_date] => 2017-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12305
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398207
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/398207 | DIRECTLY COMPRESSIBLE GRANULAR MICROCRYSTALLINE CELLULOSE BASED EXCIPIENT, MANUFACTURING PROCESS AND USE THEREOF | Jan 3, 2017 | Abandoned |
Array
(
[id] => 11588445
[patent_doc_number] => 20170112856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING CANCER IN AN INDIVIDUAL SUBJECT SUFFERING CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/397166
[patent_app_country] => US
[patent_app_date] => 2017-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8151
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15397166
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/397166 | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER IN AN INDIVIDUAL SUBJECT SUFFERING CANCER | Jan 2, 2017 | Abandoned |
Array
(
[id] => 11647792
[patent_doc_number] => 20170143693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/373604
[patent_app_country] => US
[patent_app_date] => 2016-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 33897
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15373604
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/373604 | COMPOSITIONS AND METHODS FOR TREATMENT | Dec 8, 2016 | Abandoned |
Array
(
[id] => 11647791
[patent_doc_number] => 20170143692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/372863
[patent_app_country] => US
[patent_app_date] => 2016-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 33872
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15372863
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/372863 | COMPOSITIONS AND METHODS FOR TREATMENT | Dec 7, 2016 | Abandoned |
Array
(
[id] => 13586169
[patent_doc_number] => 20180344633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => USE OF ENZYME-MODIFIED ISOQUERCITRIN
[patent_app_type] => utility
[patent_app_number] => 15/780828
[patent_app_country] => US
[patent_app_date] => 2016-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780828
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780828 | USE OF ENZYME-MODIFIED ISOQUERCITRIN | Dec 1, 2016 | Abandoned |
Array
(
[id] => 12997585
[patent_doc_number] => 10022439
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-17
[patent_title] => Allergen desensitization method
[patent_app_type] => utility
[patent_app_number] => 15/367078
[patent_app_country] => US
[patent_app_date] => 2016-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 7740
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15367078
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/367078 | Allergen desensitization method | Nov 30, 2016 | Issued |
Array
(
[id] => 11647790
[patent_doc_number] => 20170143691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/364935
[patent_app_country] => US
[patent_app_date] => 2016-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 33890
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15364935
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/364935 | COMPOSITIONS AND METHODS FOR TREATMENT | Nov 29, 2016 | Abandoned |
Array
(
[id] => 11647789
[patent_doc_number] => 20170143690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 15/357237
[patent_app_country] => US
[patent_app_date] => 2016-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 33891
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15357237
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/357237 | COMPOSITIONS AND METHODS FOR TREATMENT | Nov 20, 2016 | Abandoned |
Array
(
[id] => 11527150
[patent_doc_number] => 20170087127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'NOVEL COMPOSITION FOR NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)'
[patent_app_type] => utility
[patent_app_number] => 15/343859
[patent_app_country] => US
[patent_app_date] => 2016-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6379
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15343859
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/343859 | Composition for nonalcoholic fatty liver disease (NAFLD) | Nov 3, 2016 | Issued |
Array
(
[id] => 11434693
[patent_doc_number] => 20170035714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'Oral Dosage forms having a High Loading of a Gabapentin Prodrug'
[patent_app_type] => utility
[patent_app_number] => 15/294457
[patent_app_country] => US
[patent_app_date] => 2016-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16300
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15294457
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/294457 | Oral Dosage forms having a High Loading of a Gabapentin Prodrug | Oct 13, 2016 | Abandoned |
Array
(
[id] => 11381526
[patent_doc_number] => 20170007581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF OCULAR AND OTHER DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/273456
[patent_app_country] => US
[patent_app_date] => 2016-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20182
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15273456
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/273456 | CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF OCULAR AND OTHER DISEASES | Sep 21, 2016 | Abandoned |
Array
(
[id] => 11381526
[patent_doc_number] => 20170007581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-12
[patent_title] => 'CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF OCULAR AND OTHER DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/273456
[patent_app_country] => US
[patent_app_date] => 2016-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20182
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15273456
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/273456 | CAI-BASED SYSTEMS AND METHODS FOR THE LOCALIZED TREATMENT OF OCULAR AND OTHER DISEASES | Sep 21, 2016 | Abandoned |
Array
(
[id] => 11348757
[patent_doc_number] => 20160367497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES'
[patent_app_type] => utility
[patent_app_number] => 15/257599
[patent_app_country] => US
[patent_app_date] => 2016-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 17679
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15257599
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/257599 | METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES | Sep 5, 2016 | Abandoned |
Array
(
[id] => 11455881
[patent_doc_number] => 20170049786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-23
[patent_title] => 'MTOR PATHWAY INHIBITORS FOR TREATING OCULAR DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/254755
[patent_app_country] => US
[patent_app_date] => 2016-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 107715
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15254755
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/254755 | MTOR PATHWAY INHIBITORS FOR TREATING OCULAR DISORDERS | Aug 31, 2016 | Abandoned |
Array
(
[id] => 11269166
[patent_doc_number] => 20160331713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'METHODS FOR THE TREATMENT AND PREVENTION OF AGE-RELATED RETINAL DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 15/220315
[patent_app_country] => US
[patent_app_date] => 2016-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13469
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15220315
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/220315 | Methods for the treatment and prevention of age-related retinal dysfunction | Jul 25, 2016 | Issued |
Array
(
[id] => 11704460
[patent_doc_number] => 20170172959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'D-SERINE FOR THE TREATMENT OF VISUAL SYSTEM DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 15/220003
[patent_app_country] => US
[patent_app_date] => 2016-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4217
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15220003
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/220003 | D-SERINE FOR THE TREATMENT OF VISUAL SYSTEM DISORDERS | Jul 25, 2016 | Abandoned |
Array
(
[id] => 14067599
[patent_doc_number] => 20190082687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => MOSQUITO VECTOR CONTROL COMPOSITIONS, METHODS AND PRODUCTS UTILIZING SAME
[patent_app_type] => utility
[patent_app_number] => 15/579030
[patent_app_country] => US
[patent_app_date] => 2016-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18074
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15579030
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/579030 | Mosquito vector control compositions, methods and products utilizing same | May 30, 2016 | Issued |
Array
(
[id] => 11527186
[patent_doc_number] => 20170087158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/156125
[patent_app_country] => US
[patent_app_date] => 2016-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 106845
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15156125
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/156125 | JANUS KINASE INHIBITORS FOR TREATMENT OF DRY EYE AND OTHER EYE RELATED DISEASES | May 15, 2016 | Abandoned |